Litcius/Paper detail

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide

Robert E. J. Ryder, Katharina Laubner, Marek Beneš, Martin Haluzı́k, Lynne Munro, Harry Frydenberg, Julian Teare, Aruchuna Ruban, Sigal Fishman, Erwin Santo, R Stengel, Charlotte de Jonge, Jan Greve, Ricardo V. Cohen, Cristina Mamédio Aboud, Gerald J. Holtmann, Graeme Rich, Jess J. McMaster, Tadej Battelino, Primož Kotnik, James Byrne, John C. Mason, J. R. Bessell, Jeanine Bascomb, Lillian Kow, Janes Collins, Jacob Chisholm, Peter N. Pferschy, Harald Sourij, Melissa Cull, MELANIE C. WYRES, Russell Drummond, Barbara McGowan, Stephanie A. Amiel, Mahi Yadagiri, Piya Sen Gupta, Jens Aberle, Jochen Seufert

2023Diabetes Care17 citationsDOIOpen Access PDF

Topics & Concepts

MedicineType 2 diabetesDiabetes mellitusRisk factorGlycemicInternal medicineObesityDiseaseGastroenterologySurgeryEndocrinologyBariatric Surgery and OutcomesDiet and metabolism studiesDiabetes Treatment and Management
Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide | Litcius